Clinical Trial

Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 19, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Clinical trial to assess the real-world effectiveness of Obagi® Saypha® MagIQ™ Injectable Hyaluronic Acid (HA) gel for the treatment of mild-to-moderate facial aging, including volume loss, fine lines, and skin laxity, following treatment administered using routine clinical injection techniques over the course of 60 days.
Trial Details
NCT Number NCT07421544
Lead Sponsor Goldman, Butterwick, Fitzpatrick and Groff
Collaborators: Obagi
Conditions Fine Lines, Wrinkle, Facial Laxity, Volume Loss
Enrollment 100 participants
Start Date 2026-03-01
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-19